Xenon Pharmaceuticals (XENE) Return on Sales [ROS] (2013 - 2025)
Xenon Pharmaceuticals (XENE) recorded Return on Sales [ROS] of -4974.27% in Q4 2025, down 430.53 percentage points from the prior quarter.
Powered by 
Analysis
Xenon Pharmaceuticals (XENE) Return on Sales [ROS] (2013 - 2025) Analysis & Trends
Starting with Q3 2013, Xenon Pharmaceuticals' Return on Sales [ROS] history includes 38 quarters.
- Annual Return on Sales [ROS] has a five-year change of -4876.96 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -1368.91% in FY2022 (-940.46 pp) and -428.45% in FY2021 (-331.14 pp).
- The Q4 2025 figure is the lowest quarterly Return on Sales [ROS] since Q2 2024.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 175700.82 percentage points in Q2 2025, against a drop of 28692.85 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -4543.73% (Q3 2025), -4241.60% (Q2 2025) and -969.84% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Xenon Pharmaceuticals | 4.07 Bn | 542.89 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -4,974.27% |
| Sep 30, 2025 | -4,543.73% |
| Jun 30, 2025 | -4,241.60% |
| Mar 31, 2025 | -969.84% |
| Jun 30, 2024 | -179,942.42% |
| Mar 31, 2024 | -33,539.52% |
| Dec 31, 2022 | -1,368.91% |
| Sep 30, 2022 | -28,884.85% |
| Jun 30, 2022 | -5,655.78% |
| Mar 31, 2022 | -198.14% |
| Dec 31, 2021 | -664.65% |
| Sep 30, 2021 | -192.00% |
| Jun 30, 2021 | -1,014.34% |
| Mar 31, 2021 | -368.49% |
| Dec 31, 2020 | -250.93% |
| Sep 30, 2020 | -147.99% |
| Jun 30, 2020 | -4.83% |
| Mar 31, 2020 | -113.49% |
| Dec 31, 2019 | -348.39% |
| Sep 30, 2019 | -255.74% |
API Access
Xenon Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XENE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "XENE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XENE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();